MedPath

Open, randomised trial of the effect of aripiprazole versus risperidone on social cognition in schizophrenia

Completed
Conditions
Schizophrenia
Mental and Behavioural Disorders
Registration Number
ISRCTN61441186
Lead Sponsor
niversity Medical Centre Utrecht (UMCU) (The Netherlands)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
80
Inclusion Criteria

1. Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV) based diagnosis of schizophrenia
2. Aged 18 - 50 years
3. Active contraception
4. Intelligence quotient (IQ) greater than 80
5. Negative pregnancy test

Exclusion Criteria

1. Pregnancy
2. Lactation
3. Severe head trauma
4. Substance abuse

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath